VLPbio

VLPbio, officially The Vaccines Company, is a private Spanish biotechnology company developing human and animal vaccines based on chimeric virus-like particles. Its core technology platform, branded Q-VLP and also described as Ch-VLP, is designed to present selected antigens on pseudo-viral particles to drive targeted immune responses without genetic material. The company has highlighted oncology and infectious disease applications, including a cervical cancer vaccine candidate and animal-health vaccine programs such as infectious bursal disease in poultry. VLPbio appears to be an early-stage platform biotech focused on vaccine design and translational development rather than a commercial-stage vaccine supplier.